Quidel

Develops and markets diagnostic testing solutions

San Diego, California, United States

About Quidel

Quidel develops and manufactures diagnostic testing solutions for healthcare professionals. Their products include a variety of tests for detecting diseases, particularly in areas like infectious diseases, reproductive health, and virology. Quidel's tests, such as lateral flow tests and molecular diagnostics, work by analyzing samples to identify specific pathogens or conditions. What sets Quidel apart from competitors is their strong focus on research and development, which allows them to create faster and simpler tests, like their rapid antigen test for COVID-19 that received FDA emergency use authorization. The goal of Quidel is to provide reliable diagnostic tools that enhance patient care and support healthcare providers in managing diseases effectively.

San Diego, CaliforniaHeadquarters
1937Year Founded
$617.3KTotal Funding
IPOCompany Stage
HealthcareIndustries
501-1,000Employees

Benefits

Medical, dental, & vision
401k
Income replacement
Employee stock purchase plan
Vacation & Holidays
Great work environment

Risks

A class action lawsuit could lead to financial liabilities and reputational damage.
Increased competition from companies like Abbott and Roche in rapid diagnostics.
Integration challenges with Ortho Clinical Diagnostics may affect operational performance.

Differentiation

Quidel specializes in rapid diagnostic tests, including COVID-19 antigen tests.
The company focuses on infectious diseases, reproductive health, and virology diagnostics.
Quidel invests heavily in R&D to innovate and improve diagnostic solutions.

Upsides

Quidel's COVID-19 antigen test is faster and cheaper than traditional methods.
The acquisition of Ortho Clinical Diagnostics expands Quidel's product offerings and market reach.
Growing demand for at-home testing solutions boosts Quidel's market potential.

Funding

Total raised$617.3 K
StageIPO
GRANT
4/30/2020
$1